Neuroblastoma, Recurrent, Refractory
4 clinical trials · Condition
◉ Watch Neuroblastoma, Recurrent, Refractory
| Record | Firm | Date |
|---|---|---|
| Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors (NCT02644460) | Emory University | 2016-02-01 |
| Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors (NCT06872489) | Second Life Therapeutics |
Track Neuroblastoma, Recurrent, Refractory automatically
Every clearance here is in the API, with alerts when new ones post.